COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 914: Articles 9131-9140  | Next

Abdominal Imaging Associates Body Composition with COVID-19 Severity
Basty, N., Sorokin, E. P., Thanaj, M., Srinivasan, R., Whitcher, B., Bell, J. D., Cule, M., Thomas, E. L.
10.1101/2022.02.22.22270091 — Posted: 2022-02-24
Association of Workload and Practice of Respectful Maternity Care Among the Healthcare Providers, Before and During the COVID-19 Pandemic in South Western Nepal: A Cross-Sectional Study
Pokharel, A., Kiriya, J., Shibanuma, A., Silwal, R., Jimba, M.
10.1101/2022.02.21.22271309 — Posted: 2022-02-24
Molnupiravir (MK-4482) is efficacious against Omicron and other SARS-CoV-2 variants in the Syrian hamster COVID-19 model
Rosenke, K., Okumura, A., Lewis, M. C., Feldmann, F., Meade-White, K., Bohler, W. F., Griffin, A., Rosenke, R., Shaia, C., Jarvis, M., Feldmann, H.
10.1101/2022.02.22.481491 — Posted: 2022-02-24
Ivermectin does not protect against SARS-CoV-2 infection in the Syrian hamster model
Foo, C. S.-Y., Abdelnabi, R., Vangeel, L., De Jonghe, S., Jochmans, D., Weynand, B., Neyts, J.
10.1101/2022.02.22.481472 — Posted: 2022-02-24
SARS-CoV-2 peptide vaccine elicits T-cell responses in mice but does not protect against infection or disease
Baxter, V. K., Anderson, E. J., Taft-Benz, S. A., Olsen, K. S., Sambade, M., Gentry, K. M., Beck, W. A., Garness, J., Woods, A., Fini, M., Carpenter, B., Smith, C. C., Heise, M. T., Vincent, B. G., Rubinsteyn, A.
10.1101/2022.02.22.481499 — Posted: 2022-02-24
Effect of an amyloidogenic SARS-COV-2 protein fragment on α-synuclein monomers and fibrils
Jana, A. K., Lander, C. W., Chesney, A. D., Hansmann, U. H. E.
10.1101/2022.02.21.481360 — Posted: 2022-02-24
Omicron and Alpha P680H block SARS-CoV2 spike protein from accessing cholinergic inflammatory pathway via α9-nAChR mitigating the risk of MIS-C
Camacho, C. J., Santiago, U.
10.1101/2022.02.18.481096 — Posted: 2022-02-24
Discovery and functional interrogation of SARS-CoV-2 protein-RNA interactions
Xiang, J. S., Mueller, J. R., Luo, E.-C., Yee, B. A., Schafer, D., Schmok, J. C., Tan, F. E., Rothamel, K., McVicar, R. N., Kwong, E. M., Jones, K. L., Her, H.-L., Chen, C.-Y., Vu, A. Q., Jin, W., Park, S. S., Le, P., Brannan, K. W., Kofman, E. R., Li, Y., Tankka, A. T., Dong, K. D., Song, Y., Carlin, A. F., Van Nostrand, E. L., Leibel, S. L., Yeo, G. W.
10.1101/2022.02.21.481223 — Posted: 2022-02-24
Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation.
Torii, S., Kim, K. S., Koseki, J., Suzuki, R., Iwanami, S., Fujita, Y., Jeong, Y. D., Matsuura, Y., Shimamura, T., Iwami, S., Fukuhara, T.
10.1101/2022.02.22.481436 — Posted: 2022-02-24
A single-dose of the deactivated rabies virus vectored COVID-19 vaccine, CORAVAX, is highly efficacious and alleviates lung inflammation in the hamster model.
Schnell, M. J.
10.1101/2022.02.21.481324 — Posted: 2022-02-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).